Biotech Values

[corpstrat]

So the SEC now thinks naked shorting is a bad thing if it hurts Wall Street? Who'd have thunk?

Well, biotech investors are not part of the club, the protected class - we knew that already. Who cares if a few thousand patients die younger of / suffer more from various diseases that would have been cured if a few biotechs had had the capital to complete their trials? Nobody who matters cares.

Although we've known all this, it is fun to see it confirmed, isn't it?